China liver cancer patient registry study
Part of Cancer, Digestive system clinical trials.
This study is creating a database of people with liver cancer (including hepatocellular carcinoma and other types). It aims to collect health information and samples over time to better understand the disease and improve future care. If you join, you will be asked to provide blood and leftover tissue from surgery or biopsy, and to follow up with the research team.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your diagnosis must be one of these liver cancers: hepatocellular carcinoma, intrahepatic cholangiocarcinoma, mixed hepatocellular carcinoma-cholangiocarcinoma, or metastatic hepatocellular carcinoma.
- If you haven't had surgery, your diagnosis must be confirmed by imaging and lab tests. If you have had surgery, it must be confirmed by a pathology report.
- You must be willing to sign a consent form and allow the study team to collect blood and leftover tissue samples from your surgery or biopsy.
- You must agree to follow-up visits and share your health information.
- You cannot join if you have severe nervous system, lung, or autoimmune disease, or if you have long-term kidney failure, uncontrolled infections, or active heart problems (like recent heart attack or heart failure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects health information from patients with cancer that has spread to the liver. Researchers will track your medical history and outcomes to better understand how metastatic liver cancer develops and progresses.
This study looks at how liver cancer appears on CT or MRI scans and how it connects with the tumor's biology. It aims to find better ways to understand and treat liver cancer by linking imaging features with the tumor environment.
This study tracks patients with liver cancer who have had surgery to see how often the cancer comes back. It may help doctors better understand and predict recurrence.
This trial studies patients with liver cancer, including both the common type (hepatocellular carcinoma) and other types. It aims to understand the cancer better by collecting blood samples and medical information.
This study builds a database of information from liver cancer patients treated at Tongji Hospital. Researchers will collect your medical records and treatment information to better understand liver cancer diagnosis and care over time.
This study looks at blood and tissue samples from people with liver cancer to find markers that can predict how well treatment works and whether the cancer might come back. It may help doctors personalize treatment and follow-up care.
Hear when a new Liver Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.